Skip to main content
Noul Co., Ltd. logo

Noul Co., Ltd. — Investor Relations & Filings

Ticker · 376930 ISIN · KR7376930004 KO Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country KR South Korea
Listing KO 376930

About Noul Co., Ltd.

https://noul.com/en/

Noul Co., Ltd. is a biotechnology company that develops innovative diagnostic solutions for blood and tissue analysis. The company's core product is the miLab™ platform, an all-in-one, fully automated medical device that integrates the entire diagnostic process from sample staining and digital imaging to artificial intelligence (AI)-powered analysis. This technology is designed to provide rapid and accurate diagnoses for blood-based diseases and cancer, with a focus on improving healthcare accessibility and diagnostic efficiency in various settings, including those with limited resources. Noul aims to address global health challenges by delivering advanced in-vitro and remote diagnostic capabilities.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2026-06-02 Korean
주주총회소집결의
Regulatory Filings
2026-06-02 Korean
주식병합결정
Regulatory Filings
2026-06-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is an "임원ㆍ주요주주 특정증권등 소유상황보고서" (Officer/Major Shareholder Report on Ownership of Specific Securities), detailing insider shareholdings, changes, and transaction details by a company director. This aligns exactly with the definition of Director’s Dealing (DIRS).
2026-05-22 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a brief announcement of an upcoming investor relations roadshow (Non-Deal Roadshow) event—date, location, audience, and details on IR material posting—rather than an actual presentation deck or substantive financial report. It does not contain financial statements or slides; it is a regulatory disclosure notice. This aligns with the fallback “Regulatory Filings” category for miscellaneous regulatory announcements.
2026-05-18 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 70% confidence The document is a Korean-language regulatory disclosure announcing a single sales and supply contract and an amendment (correction) to its terms. It details contract periods, payment conditions, counterparties, and related financial amounts. There is no indication of financial statements or management discussion typical of interim reports, nor is it announcing dividends, share issuances, or executive changes. It is a standard regulatory announcement of a material contract and related amendment. There is no specific category for commercial contract disclosures other than the generic regulatory filings category. Therefore, the document is best classified as a Regulatory Filing (RNS).
2026-05-15 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.